133 filings
8-K
NBRVF
Nabriva Therapeutics plc
31 Jul 23
Entry into a Material Definitive Agreement
8:07am
8-K
NBRVF
Nabriva Therapeutics plc
24 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
NBRVF
Nabriva Therapeutics plc
7 Jul 23
Departure of Directors or Certain Officers
4:34pm
8-K
NBRVF
Nabriva Therapeutics plc
1 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
NBRVF
Nabriva Therapeutics plc
3 Feb 23
Entry into a Material Definitive Agreement
8:45pm
8-K
dqci5a
20 Jan 23
Departure of Directors or Certain Officers
6:00am
8-K
ax8k2d0q3 y75b
9 Jan 23
Termination of a Material Definitive Agreement
4:13pm
8-K
nwuhl ioml4o
28 Nov 22
Other Events
8:01am
8-K
jr0vynwsblje
10 Nov 22
Nabriva Therapeutics Pivoting Strategic Focus
4:08pm
8-K
z5lqq54q26 gk
4 Oct 22
Other Events
4:03pm
8-K
3kt78ltszp
16 Sep 22
Material Modifications to Rights of Security Holders
6:02am
8-K
7ya1y
17 Aug 22
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
ca0c8
11 Aug 22
Other Events
8:23am
8-K
l6r42 cw53g
3 Aug 22
Nabriva Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
4:02pm
8-K
bvammksp q1vyv43
6 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
8-K
k35uw r8q8d0tqwknz
5 May 22
Nabriva Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update
4:01pm
8-K
nriw zawdsw3
29 Mar 22
Nabriva Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
4:01pm
8-K
jeb5nwv v1elz1o9iv
24 Mar 22
Submission of Matters to a Vote of Security Holders
5:07pm
8-K
a9eh 7vmi
2 Feb 22
Departure of Directors or Certain Officers
4:13pm
8-K
40eket ikz
18 Jan 22
Other Events
4:25pm